Precision Biopsy Expands the Clinical Trial of Its ClariCore Biopsy System in Prostate Cancer Patients

News Equipped with an optical fiber and companion console, the ClariCore system performs spectral analysis of prostate tissue during biopsy, providing in-vivo tissue classification that seeks to minimize the number of normal core samples taken by up to 90 percent. Contributed Author:  Precision Biopsy, Inc. Topics:  Oncology